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Target Organ Toxicity: The Blood and
Bone Marrow
Introduction
by Richard D. Irons*
In recent years there has been rapid growth in
the sophistication of investigative approaches in
hematology primarily associated with the study of
leukemogenesis and blood dyscrasias in man and
closely allied with the evaluation of antineoplastic
drugs. The purpose of this conference was to
encourage a similar approach to the study of
chemically induced myelotoxicity by promoting dis-
cussion among investigators, toxicologists and
clinicians sharing a common interest in the blood
and bone marrow as targets for toxicity.
The blood and bone marrow represent a widely
dispersed organ system comprised of a heteroge-
neous population of cells. The cellular constituents
of the blood and bone marrow are divided into
several different lines or pathways of differentia-
tion resulting in the production of mature erythro-
cytes, granulocytes, lymphocytes, macrophages,
and thrombocytes. Chemical agents may demon-
strate selective toxicity to individual cell types,
cells in particular stages of differentiation, or may
be toxic to all hematopoietic cells. Exposure to
toxic agents may result in an alteration in the
number ofcells, their function, or both. Myelotoxic
insult can be manifested through destruction ofthe
formed elements of the blood, inhibition of mature
cell function, destruction of precursor cells or
impaired cell growth and regulation. Impairment
may be transitory, in the case of drug-induced
leukopenia, or permanent, with the onset ofaplastic
anemia. As a result of the complexity of these
processes and the inherent resiliency of the
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hematopoietic regulatory process, real or potential
risks are often difficult to assess.
A characteristic contributing to the sensitivity of
the hematopoietic system to chemical insult is the
high rate of cell turnover and DNA synthesis. The
importance of understanding the nature and com-
plexity of cell kinetics in conferring susceptibility
on hematopoietic cells emerges as a recurring
theme in many ofthe presentations. Drs. Mangalik
and Robinson, in their paper, contrast the
hematopoietic system, along with the gastrointes-
tinal mucosa and skin, to most other organ systems
which are comprised of differentiated cells with
limited or no capacity for self-renewal. Dr. Heddle
underscores the role of cell division in the expres-
sion of chromosomal damage and illustrates the
sensitivity and the accuracy of the micronucleus
test as a nonspecific indicator ofmutagenic damage.
In presentations by Drs. Heddle, Lee, Marsh,
Dritschilo, and me, it is repeatedly illustrated that
there are significant variations in the susceptibility
of proliferating cells to chemical or radiation insult
as a function of cell cycle phase at the time of
exposure.
I describe the application offlow cytofluorometric
DNA analysis for use as a sensitive indicator of
cycle specific changes in bone marrow proliferative
activity occurring as a consequence of exposure to
agents such as benzene. Drs. Lee, Kocsis, and
Snyder discuss the utility of using ferrokinetics to
assess erythropoietic toxicity and to determine the
effects of chemical exposure on various stages of
differentiation in erythroid cells. They have found
it to offer increased sensitivity over routine
morphometricmethods. Drs. Mangalikand Robinson
and Marsh pointoutthatthe kinetics ofgranulopoiesis
and release of mature granulocytes are more com-
1plex than described forthe erythroid line, primarily
due to a variety of factors governing circulating
neutrophil numbers such as margination and bone
marrow reserve.
Because ofthese factors, as well as the relatively
long lifespan of erythrocytes in the peripheral
blood, the general consensus was that peripheral
blood counts are insensitive and often inaccurate
reflections ofhematopoietic activity. Most toxicolo-
gistsroutinely employperipheral hematology counts
as an indicator of myelotoxicity; however, assess-
ments of early effects of chemical agents on the
hematopoietic system are better made in the con-
text of bone marrow precursor cell number and
turnover.
Our knowledge of stem cell origin and function
has rapidly grown in sophistication over the past
few years. Drs. Mangalik and Robinson review
advances in the development of stem cell assays
including the recently described Dexter technique
for the culture of hematopoietic cells. Dr. Marsh
discusses the potential advantages of the agar
diffusion chamber precursor cell assay (ADCPC)
for assessing the effects of chemical agents on
granulocyte and macrophage precursor cells. The
ADCPC assay is an in vivo modification of the-
CFC-C culture technique in which the effects of
chemical agents can be assessed on clonigenic cells
in vivo. These assay procedures have seen only
limited use in the past for the evaluation of
environmentally induced myelotoxicity, but are
now being used with increasing frequency to de-
termine the toxic potential of chemicals toward
bone marrow stem cell populations.
Drs. Rickert and Nebert call attention to the
importance of pharmacokinetic, disposition, and
metabolism studies in evaluating the myelotoxic
potential ofachemical agent. In addition to outlining
some of the special problems encountered in the
analysis of blood and bone marrow samples, Dr.
Rickert describes the usefulness and limitations of
newer sophisticated instrumentation such as gas
chromatography-mass spectroscopy and high per-
formance liquid chromatography. These techniques
have the requisite specificity and sensitivity to
overcome some of the challenges presented in the
analysis of small tissue samples such as bone
marrow. Dr. Rickert describes their application to
the analysis ofbenzene and its metabolites in blood
and bone marrow. Dr. Nebert emphasizes the
importance of dose and route of administration in
interpreting genetically controlled differences in
susceptibility to chemically induced bone marrow
toxicity in different strains of mice. He illustrates
this point with a description of differences in the
inducibility of mixed function oxidase activity con-
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trolled by the Ah locus which gave rise to different
patterns of toxicity in response to benzo[a]pyrene
administration. This presentation points to the
potential importance ofgenetically determined het-
erogeneity in governing the response to environ-
mental stimuli, a concept again borne out in Dr.
Piomelli'sdiscussion oferythrocyte G6-PDdeficiency
in man.
Drs. Adamson and Sieber review our current
knowledge of the phenomena associated with
chemically induced leukemia in man. They empha-
sized the critical lack of appropriate animal models
for the study ofhuman leukemogenesis. Although a
number ofchemical agents have been recognized to
produce leukemia or lymphoma in experimental
animals, the characteristics and progression of
these malignancies in rodents do not closely resem-
ble those observed in man. These differences seri-
ously cloud the extrapolation of experimental data
to humans.
Detailed aspects of studying chemical toxicity to
the granulocyte are discussed by Dr. Marsh, who
reviews the structure, kinetics, and function of the
polymorphonuclear leukocyte and its role in mediat-
ing inflammatory response and phagocytosis of
microorganisms. Specific examples of chemothera-
peutic agents which possess different activities
toward granulocyte precursor cells were presented.
In the context ofpresenting recent clinical findings
related to combined radiation and chemotherapeu-
tic modalities, Dr. Dritschilo reviews important
differences in myelotoxic response between indi-
vidual and concurrent radiation or chemical expo-
sure. His presentation calls our attention to the
potential significance of biologic interactions in
evaluating environmentally induced myelotoxicity.
Dr. Piomelli presents examples of two different
types of chemical toxicity to the red cell. A direct
effect on mature erythrocytes brought about by a
genetically determined deficiency in G-6-PD lead-
ing to an increased susceptibility to drug-induced
hemolysis and the effects of lead on hemoglobin
synthesis and iron incorporation into protoporphy-
rin.
Dr. Loose outlines the role ofthe macrophage in
phagocytosis as well as initiation and amplification
of the immune response. He reminds us of the
underlying relevance ofalterations in leukocyte and
macrophage function, namely, that suppression of
specific cell function does result in an increased
susceptibility to bacterial, viral, or parasitic infec-
tion as well as increased susceptibility to accep-
tance of tumor transplants in syngeneic hosts. Dr.
Loose also illustrates the complexity involved in
evaluating alterations in cell function by distin-
guishing between a direct biochemical effect on
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fect on macrophage phagocytic response via inter-
ference withtheserumopsonin, fibronectin. Although
the lymphocyte is more often considered within the
context of immunology, its origin and role within
the hematopoietic system render it an important
aspect of any discussion concerning hematologic
response to toxic agents. Drs. Silkworth and Loose,
in their contributed paper, provide an overview of
approaches available for the study of lymphocyte
function and discuss factors to be considered in the
assessment of chemically-induced immunotoxicity.
In the past, toxicologic investigations of poten-
tiallymyelotoxic agents have been largelyrestricted
to analysis of hemograms and the numbers of
circulating peripheral blood elements. Recent ad-
vances in experimental hematology have resulted
in an increased awareness of the importance of
understanding the dynamics ofhematologic regula-
tion and function and have provided the toxicologist
with new and sensitive tools for the study of
induced myelotoxicity.
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